NLRP3 and cerebrovascular disorder: By inhibiting microtubule polymerization and suppressing the NLRP3 inflammasome, colchicine reduces the production of pro-inflammatory cytokines such as interleukin-1β and interleukin-6, both of which have been implicated in the pathogenesis of cerebrovascular disease [22].